Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of quisinostat in combination with chemotherapy in patients with non-small cell lung can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Quisinostat (quisinostat)

Snippet

Sponsor: NewVac LLC | Conditions: Non-small Cell Lung Cancer, Epithelial Ovarian Cancer | Phase 1 | Status: COMPLETED